BALA MURUGAN

Dr. BALA MURUGAN

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
BMBALA MURUGAN
BALA MURUGAN
DDDipankar Das
Dipankar Das
MHMurat Hasanreisoglu
Murat Hasanreisoglu
BTBrian C Toy
Brian C Toy
MAMashal Akhter
Mashal Akhter
KKKirandeep Kaur
Kirandeep Kaur
Interleukins and cytokines are involved in the pathogenesis of uveitis of heterogeneous origin. Understanding the basics of the ocular immune privilege is a fulcrum to discern their specific role in diverse uveitis to potentially translate as therapeutic targets. This review attempts to cover these elements in uveitis of infectious, noninfectious and masquerade origin. Insights of the molecular targets in novel therapy along with the vision of future research are intriguing.

1 December 2024 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
BMBALA MURUGAN
BALA MURUGAN
SSSrinivasan Sanjay
Srinivasan Sanjay
ASAnjana Somanath
Anjana Somanath
PMPadmamalini Mahendradas
Padmamalini Mahendradas
APAditya Patil
Aditya Patil
BGBharat Gurnani
Bharat Gurnani
In the dynamic field of ophthalmology, artificial intelligence (AI) is emerging as a transformative tool in managing complex conditions like uveitis. Characterized by diverse inflammatory responses, uveitis presents significant diagnostic and therapeutic challenges. This systematic review explores the role of AI in advancing diagnostic precision, optimizing therapeutic approaches, and improving patient outcomes in uveitis care. A comprehensive search of PubMed, Scopus, Google Scholar, Web of Science, and Embase identified over 10,000 articles using primary and secondary keywords related to AI and uveitis. Rigorous screening based on predefined criteria reduced the pool to 52 high-quality studies, categorized into six themes: diagnostic support algorithms, screening algorithms, standardization of Uveitis Nomenclature (SUN), AI applications in management, systemic implications of AI, and limitations with future directions. AI technologies, including machine learning (ML) and deep learning (DL), demonstrated proficiency in anterior chamber inflammation detection, vitreous haze grading, and screening for conditions like ocular toxoplasmosis. Despite these advancements, challenges such as dataset quality, algorithmic transparency, and ethical concerns persist. Future research should focus on developing robust, multimodal AI systems and fostering collaboration among academia and industry to ensure equitable, ethical, and effective AI applications. The integration of AI heralds a new era in uveitis management, emphasizing precision medicine and enhanced care delivery.

24 January 2022 in Ophthalmology
Verified
Journal Article
Closed access
ABAnh D. Bui
Anh D. Bui
CKChristina L. Kong
Christina L. Kong
NKNicole K. Kelly
Nicole K. Kelly
SRS.R. Rathinam
S.R. Rathinam
JGJohn A. Gonzales
John A. Gonzales
NANisha R. Acharya
Nisha R. Acharya

1 January 2019 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
BMBALA MURUGAN
BALA MURUGAN

17 May 2023 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
BMBALA MURUGAN
BALA MURUGAN
ASAnjana Somanath
Anjana Somanath

26 August 2022 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
BMBALA MURUGAN
BALA MURUGAN
ASAnjana Somanath
Anjana Somanath